Clinical Trial Update: The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects. [Phase 4]

View source ↗

Summary

The University of Aarhus-sponsored Phase 4 trial evaluating the cardiopulmonary effects of inhaled beta-2-adrenergic agonists in adults with a ventricular septa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Septal Defect

Drugs mentioned

• Inhaled beta-2-adrenergic agonists (beta-2 adrenergic agonist (inhaled))

Snippet

Sponsor: University of Aarhus | Conditions: Ventricular Septal Defect | Phase 4 | Status: COMPLETED